Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease. Academic Article uri icon

Overview

abstract

  • Riege and Metter provide a useful review of the application of PET in the evaluation of Alzheimer's disease (AD). We share their enthusiasm for continued support and development of tools to image metabolic processes. Our commentary focuses on neuroimaging and the diagnosis of AD and introduces some new data that directly impacts on the interpretation of PET-2-deoxyglucose (2DG) data.

publication date

  • January 1, 1988

Research

keywords

  • Alzheimer Disease
  • Deoxy Sugars
  • Deoxyglucose
  • Tomography, Emission-Computed

Identity

Scopus Document Identifier

  • 0023830688

Digital Object Identifier (DOI)

  • 10.1016/s0197-4580(88)80029-0

PubMed ID

  • 3260012

Additional Document Info

volume

  • 9

issue

  • 1